Literature DB >> 12770698

Absence of association between Alzheimer disease and the regulatory region polymorphism of the PS2 gene in an Italian population.

Manuela Di Natale1, Maria Perri, Toshitaka Kawarai, Raffaele Maletta, Carmine Tomaino, Christine Sato, Benedetta Nacmias, Nobuto Shibata, Sandro Sorbi, Peter H St George-Hyslop, Amalia C Bruni, Ekaterina Rogaeva.   

Abstract

Alzheimer disease (AD) is the most common neurodegenerative disorder of aging. Identifying novel AD genetic risk factors is important for understanding its pathogenesis. A recent study demonstrated that the deletion of adenosine in the promoter region of the presenilin 2 gene (PS2) is a susceptibility factor for early-onset AD. The objective of our study was to test the possibility that this variation is associated with AD in the Italian population. A case-control association study was performed, using 200 sporadic AD cases and 160 normal controls matched by age, gender and ethnicity. The current study does not support the notion that the polymorphism in the PS2 gene constitutes a risk factor for either late-onset or early-onset AD, which means that other genetic factors play a role in the development of AD in the Italian population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770698     DOI: 10.1016/s0304-3940(03)00335-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

Review 1.  Current status on Alzheimer disease molecular genetics: from past, to present, to future.

Authors:  Karolien Bettens; Kristel Sleegers; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2010-04-13       Impact factor: 6.150

2.  Two polymorphisms of presenilin-2 gene (PSEN2) 5' regulatory region are not associated with Alzheimer's disease (AD) in the Polish population.

Authors:  M Gacia; K Safranow; T Gabryelewicz; M Styczyńska; B Pepłońska; V Dziedziejko; K Jakubowska; D Chlubek; C Zekanowski; M Barcikowska
Journal:  J Neural Transm (Vienna)       Date:  2007-12-18       Impact factor: 3.575

3.  Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer Patients.

Authors:  M Zamani; M Mehri; A Kollaee; P Yenki; M Ghaffarpor; M H Harirchian; M Shahbazi
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-06-29

4.  Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population.

Authors:  Ayako Suzuki; Nobuto Shibata; Koji Kasanuki; Tomoyuki Nagata; Shunichiro Shinagawa; Nobuyuki Kobayashi; Tohru Ohnuma; Yoshihide Takeshita; Eri Kawai; Toshiki Takayama; Kenya Nishioka; Yumiko Motoi; Nobutaka Hattori; Kazuhiko Nakayama; Hisashi Yamada; Heii Arai
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.